Pure Global
NCT05412914

Remimazolam and Propofol on the Left Ventricular Strain During Anesthesia Induction for Non-cardiac Surgery

The Impact of Remimazolam and Propofol on the Left Ventricular Systolic Performance During Anesthesia-induction for Non-cardiac Surgery: a Speckle Tracking Analysis of the Left Ventricular Strain Using Transthoracic Echocardiography
Konkuk University Medical Center·Phase 4·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Procedure, Unspecified
Drug/Device/Intervention
Remimazolam infusion
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Konkuk University Medical Center
Timeline & enrollment
Phase
Phase 4
Start date
Aug 01, 2022
End date
Sep 01, 2023
Enrollment
40 participants
Primary outcome

the longitudinal strain change of the left ventricle (%)

Summary

This study to compare the impacts of remimazolam or propofol on the left ventricular global
 longitudinal strain (LV-GLS) during anesthesia induction for non-cardiac surgery.
 
 LV-GLS is analyzed by using speckle tracking technique of transthoracic echocardiography.

ICD-10 classifications
Surgical procedure, unspecifiedMedical procedure, unspecifiedOther surgical proceduresDuring unspecified surgical and medical careDuring unspecified surgical and medical care
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05412914
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05412914 through Pure Global AI's free database. This Phase 4 trial is sponsored by Konkuk University Medical Center and is currently Not yet recruiting. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.